PHENDIMETRAZINE TARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phendimetrazine Tartrate, and when can generic versions of Phendimetrazine Tartrate launch?
Phendimetrazine Tartrate is a drug marketed by Graham Dm, Virtus, Sandoz, Vitarine, Barr, Chartwell, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Nexgen Pharma Inc, Nostrum Labs Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.
The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phendimetrazine Tartrate
A generic version of PHENDIMETRAZINE TARTRATE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENDIMETRAZINE TARTRATE?
- What are the global sales for PHENDIMETRAZINE TARTRATE?
- What is Average Wholesale Price for PHENDIMETRAZINE TARTRATE?
Summary for PHENDIMETRAZINE TARTRATE
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 65 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 1,902 |
Drug Prices: | Drug price information for PHENDIMETRAZINE TARTRATE |
What excipients (inactive ingredients) are in PHENDIMETRAZINE TARTRATE? | PHENDIMETRAZINE TARTRATE excipients list |
DailyMed Link: | PHENDIMETRAZINE TARTRATE at DailyMed |
Pharmacology for PHENDIMETRAZINE TARTRATE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |